Lenalidomide in lymphomas and chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Lenalidomide in lymphomas and chronic lymphocytic leukemia

Published:2013-01-29 Issue:4 Volume:14 Page:475-488
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Wiernik Peter H¹

Affiliation:

1. Continuum Cancer Centers of New York, St. Lukes – Roosevelt and Beth Israel Medical Center, Leukemia Program, 1000 10th Ave, Ste. 11C-02, New York, NY 10019, USA ; ;

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14656566.2013.765858

Reference111 articles.

1. Thalidomide and lenalidomide: Mechanism-based potential drug combinations

2. Thalidomide Analogues as Anticancer Drugs

3. Thalidomide: Mechanisms of Action

4. The application and biology of immunomodulatory drugs (IMiDs) in cancer

5. Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of the Thermal Conductivities of Methyl 2-Methyl-3-nitrobenzoate + Acetonitrile, N-Bromosuccinimide + Acetonitrile, and Methyl 2-Methyl-3-nitrobenzoate + N-Bromosuccinimide + Acetonitrile in the Temperature Range from 300 to 340 K;Journal of Chemical & Engineering Data;2023-09-13

2. Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway;International Immunopharmacology;2022-02

3. Antiangiogenic drugs as chemosensitizers in hematological tumors;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022

4. The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines;Cancer Biology & Therapy;2016-08-12

5. Genetic and molecular targets in lymphoma: implications for prognosis and treatment;Future Oncology;2014-12